LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition

Biology Open

Volumn 3, Issue 2, 2014, Pages 129-137

  Cuevas, Eva P ^a   Moreno Bueno, Gema ^a,b   Canesin, Giacomo ^a,c   Santos, Vanesa ^a   Portillo, Francisco ^a   Cano, Amparo ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b MD ANDERSON CANCER CENTER   (Spain)

^c Clinical Research Center   (Sweden)

Author keywords

EMT; FAK; LOXL2; Lysyl oxidase; Src

Indexed keywords

EID: 84979009498     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.20146841     Document Type: Article

References (40)

1. Alley, M. C., Scudiero, D. A., Monks, A., Hursey, M. L., Czerwinski, M. J., Fine, D. L., Abbott, B. J., Mayo, J. G., Shoemaker, R. H. and Boyd, M. R. (1988). Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48, 589-601.
2. Alt-Holland, A., Sowalsky, A. G., Szwec-Levin, Y., Shamis, Y., Hatch, H., Feig, L. A. and Garlick, J. A. (2011). Suppression of E-cadherin function drives the early stages of Ras-induced squamous cell carcinoma through upregulation of FAK and Src. J. Invest. Dermatol. 131, 2306-2315.
3. Barker, H. E., Chang, J., Cox, T. R., Lang, G., Bird, D., Nicolau, M., Evans, H. R., Gartland, A. and Erler, J. T. (2011). LOXL2-mediated matrix remodeling in metastasis and mammary gland involution. Cancer Res. 71, 1561-1572.
4. Barry-Hamilton, V., Spangler, R., Marshall, D., McCauley, S., Rodriguez, H. M., Oyasu, M., Mikels, A., Vaysberg, M., Ghermazien, H., Wai, C. et al. (2010). Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat. Med. 16, 1009-1017.
5. Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J. and García De Herreros, A. (2000). The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2, 84-89.
6. Bolós, V., Peinado, H., Pérez-Moreno, M. A., Fraga, M. F., Esteller, M. and Cano, A. (2003). The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci. 116, 499-511.
7. Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F. and Nieto, M. A. (2000). The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2, 76-83.
8. Cano, A., Santamaría, P. G. and Moreno-Bueno, G. (2012). LOXL2 in epithelial cell plasticity and tumor progression. Future Oncol. 8, 1095-1108.
9. Csiszar, K. (2001). Lysyl oxidases: a novel multifunctional amine oxidase family. Prog. Nucleic Acid Res. Mol. Biol. 70, 1-32.
10. Espada, J., Peinado, H., Lopez-Serra, L., Setién, F., Lopez-Serra, P., Portela, A., Renart, J., Carrasco, E., Calvo, M., Juarranz, A. et al. (2011). Regulation of SNAIL1 and E-cadherin function by DNMT1 in a DNA methylation-independent context. Nucleic Acids Res. 39, 9194-9205.
11. Fux, L., Feibish, N., Cohen-Kaplan, V., Gingis-Velitski, S., Feld, S., Geffen, C., Vlodavsky, I. and Ilan, N. (2009). Structure-function approach identifies a COOHterminal domain that mediates heparanase signaling. Cancer Res. 69, 1758-1767.
12. Hata, A., Seoane, J., Lagna, G., Montalvo, E., Hemmati-Brivanlou, A. and Massagué, J. (2000). OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 100, 229-240.
13. Herranz, N., Dave, N., Millanes-Romero, A., Morey, L., Díaz, V. M., Lórenz-Fonfría, V., Gutierrez-Gallego, R., Jerónimo, C., Di Croce, L., García de Herreros, A. et al. (2012). Lysyl oxidase-like 2 deaminates lysine 4 in histone H3. Mol. Cell 46, 369-376.
14. Hohenester, E., Sasaki, T. and Timpl, R. (1999). Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily. Nat. Struct. Biol. 6, 228-232.
15. Hollosi, P., Yakushiji, J. K., Fong, K. S. K., Csiszar, K. and Fong, S. F. T. (2009) Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells. Int. J. Cancer 125, 318-327.
16. Jourdan-Le Saux, C., Tronecker, H., Bogic, L., Bryant-Greenwood, G. D., Boyd, C. D. and Csiszar, K. (1999). The LOXL2 gene encodes a new lysyl oxidase-like protein and is expressed at high levels in reproductive tissues. J. Biol. Chem. 274, 12939-12944.
17. Lopez, K. M. and Greenaway, F. T. (2011). Identification of the copper-binding ligands of lysyl oxidase. J. Neural Transm. 118, 1101-1109.
18. Lucero, H. A. and Kagan, H. M. (2006). Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell. Mol. Life Sci. 63, 2304-2316.
19. Lugassy, J., Zaffryar-Eilot, S., Soueid, S., Mordoviz, A., Smith, V., Kessler, O. and Neufeld, G. (2012). The enzymatic activity of lysyl oxidas-like-2 (LOXL2) is not required for LOXL2-induced inhibition of keratinocyte differentiation. J. Biol. Chem. 287, 3541-3549.
20. Martínez, V. G., Moestrup, S. K., Holmskov, U., Mollenhauer, J. and Lozano, F. (2011). The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis. Pharmacol. Rev. 63, 967-1000.
21. Martínez-Estrada, O. M., Cullerés, A., Soriano, F. X., Peinado, H., Bolós, V., Martínez, F. O., Reina, M., Cano, A., Fabre, M. and Vilaró, S. (2006). The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. Biochem. J. 394, 449-457.
22. Millanes-Romero, A., Herranz, N., Perrera, V., Iturbide, A., Loubat-Casanovas, J., Gil, J., Jenuwein, T., García de Herreros, A. and Peiró, S. (2013). Regulation of heterochromatin transcription by Snail1/LOXL2 during epithelial-to-mesenchymal transition. Mol. Cell 52, 746-757.
23. Molnar, J., Fong, K. S., He, Q. P., Hayashi, K., Kim, Y., Fong, S. F., Fogelgren, B., Szauter, K. M., Mink, M. and Csiszar, K. (2003). Structural and functional diversity of lysyl oxidase and the LOX-like proteins. Biochim. Biophys. Acta 1647, 220-224.
24. Moreno-Bueno, G., Peinado, H., Molina, P., Olmeda, D., Cubillo, E., Santos, V., Palacios, J., Portillo, F. and Cano, A. (2009). The morphological and molecular features of the epithelial-to-mesenchymal transition. Nat. Protoc. 4, 1591-1613.
25. Moreno-Bueno, G., Salvador, F., Martín, A., Floristán, A., Cuevas, E. P., Santos, V., Montes, A., Morales, S., Castilla, M. A., Rojo-Sebastián, A. et al. (2011). Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas. EMBO Mol Med. 3, 528-544.
26. Nieto, M. A. and Cano, A. (2012). The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin. Cancer Biol. 22, 361-368.
27. Palamakumbura, A. H. and Trackman, P. C. (2002). A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples. Anal. Biochem. 300, 245-251.
28. Peinado, H., Ballestar, E., Esteller, M. and Cano, A. (2004). Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/ HDAC2 complex. Mol. Cell. Biol. 24, 306-319.
29. Peinado, H., Del Carmen Iglesias-de la Cruz, M., Olmeda, D., Csiszar, K., Fong, K. S., Vega, S., Nieto, M. A., Cano, A. and Portillo, F. (2005a). A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J. 24, 3446-3458.
30. Peinado, H., Portillo, F. and Cano, A. (2005b). Switching on-off Snail: LOXL2 versus GSK3beta. Cell Cycle 4, 1749-1752.
31. Peinado, H., Olmeda, D. and Cano, A. (2007). Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 7, 415-428.
32. Peinado, H., Moreno-Bueno, G., Hardisson, D., Pérez-Gómez, E., Santos, V., Mendiola, M., de Diego, J. I., Nistal, M., Quintanilla, M., Portillo, F. et al. (2008) Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas. Cancer Res. 68, 4541-4550.
33. Peiró, S., Escrivà, M., Puig, I., Barberà, M. J., Dave, N., Herranz, N., Larriba, M. J., Takkunen, M., Francí, C., Muñoz, A. et al. (2006). Snail1 transcriptional repressor binds to its own promoter and controls its expression. Nucleic Acids Res. 34, 2077-2084.
34. Peng, L., Ran, Y. L., Hu, H., Yu, L., Liu, Q., Zhou, Z., Sun, Y. M., Sun, L. C., Pan, J., Sun, L. X. et al. (2009). Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway. Carcinogenesis 30, 1660-1669.
35. Polyak, K. and Weinberg, R. A. (2009). Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265-273.
36. Saito, H., Papaconstantinou, J., Sato, H. and Goldstein, S. (1997). Regulation of a novel gene encoding a lysyl oxidase-related protein in cellular adhesion and senescence. J. Biol. Chem. 272, 8157-8160.
37. Schaller, M. D. (2010). Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions. J. Cell Sci. 123, 1007-1013.
38. Sobrado, V. R., Moreno-Bueno, G., Cubillo, E., Holt, L. J., Nieto, M. A., Portillo, F. and Cano, A. (2009). The class I bHLH factors E2-2A and E2-2B regulate EMT. J. Cell Sci. 122, 1014-1024.
39. Thiery, J. P., Acloque, H., Huang, R. Y. and Nieto, M. A. (2009). Epithelialmesenchymal transitions in development and disease. Cell 139, 871-890.
40. Xu, L., Go, E. P., Finney, J., Moon, H., Lantz, M., Rebecchi, K., Desaire, H. and Mure, M. (2013). Post-translational modifications of recombinant human lysyl oxidase-like 2 (rhLOXL2) secreted from Drosophila S2 cells. J. Biol. Chem. 288, 5357-5363.